The allocation of scarce healthcare resources inherently involves trade-offs between the interests of ‘visible’ and ...

The pace of scientific advancements in medicine, driven by artificial intelligence as much as by novel biotechnologies, ...

Given that only a small fraction of patients with cancer exhibits specific markers making them eligible for effective ...

Response: arguments to abolish the legal age limits of access to information about the gamete donor by donor offspring (26 July, 2024) ...

Keeping the humans in the loop: why surrogate human decision-makers remain necessary with personalised patient preference predictors (P4) use ...

Correspondence to G M Qurashi, Green Templeton College, University of Oxford, Oxford OX1 2JD, UK; mail.mustafaqurashi{at}gmail.com The Organ Donation Act 2019 has introduced an opt-out organ donor ...

Mr M Doucet, Department of Philosophy, John Watson Hall, Queen’s University, Kingston, Ontario, Canada K7L 3N6; 1wmd1{at}queensu.ca More than 40 primary studies, and three recent systematic reviews ...

Correspondence to Dr Brian D Earp, Uehiro Centre for Practical Ethics, University of Oxford, Oxford, England; brian.earp{at}philosophy.ox.ac.uk “Baby T” is a critically ill newborn delivered ...

Radboud University Nijmegen Medical Centre, Department of Ethics, Philosophy and History of Medicine, Nijmegen, The Netherlands Martien A M Pijnenburg, Radboud University Nijmegen Medical Centre, Dep.